Search

everythinglearnresearchcommunity

for

Search:↓

Cetuximab can cause unusual hair growth and hair loss.

A TP63 gene mutation causes significant hair loss and mild skin, nail, and tooth abnormalities.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Cross-section trichometry is an accurate method to measure hair loss and growth.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Finasteride is effective in stopping hair loss and promoting regrowth in most men with mild side effects.

A medication for skin rash also unexpectedly treated hair loss in a patient.

The treatment improved hair color in most vitiligo patients without major side effects.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Alopecia areata is a hair loss condition that may be linked to stress and genetics, often requires psychological support, and has no set treatment.

A woman experienced excessive hair growth after using a hair loss treatment with minoxidil.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

A patient produced cortisol after adrenalectomy, possibly due to residual tissue or other body parts making steroids.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Syphilis can cause hair loss that looks like other conditions, but it improves with treatment.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

There is no cure for alopecia areata, and treatment success depends on the individual's situation.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

Hirsutism causes significant psychological distress in women.

A rare autoimmune condition, Satoyoshi syndrome, can start in adults and improve with immunosuppressive treatment.